Jun 7, 2024, 16:55
Sunil Verma: Day 1 in AstraZeneca as SVP, Global Head, Oncology Franchise
Sunil Verma shared on X: .
“Day 1 in the new role, I am pleased to share that I am taking on a new role at AstraZeneca as SVP, Global Head, Oncology Franchise.
In this role, I have the privilege of leading global teams bringing our cancer therapies to patients impacted by cancer with a focus on solid tumors”
Source: Sunil Verma/X
Sunil Verma is the Global Head of Oncology, Medical at AstraZeneca’s Oncology Business Unit. He previously led AstraZeneca’s global research and development in breast cancer, developing a leading clinical development program. With nearly 15 years as a Medical Oncologist, Verma has conducted pivotal trials in breast and lung cancer, with his work published in over 125 peer-reviewed journals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 09:39
Nov 13, 2024, 08:59